Heron Therapeutics
HRTX
HRTX
176 hedge funds and large institutions have $289M invested in Heron Therapeutics in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 59 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
25% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 32
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
43% less capital invested
Capital invested by funds: $510M → $289M (-$220M)
Holders
176
Holding in Top 10
2
Calls
$2.61M
Puts
$124K
Top Buyers
| 1 | +$23.1M | |
| 2 | +$6.25M | |
| 3 | +$4.56M | |
| 4 |
CC
Clearline Capital
New York
|
+$2.56M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.79M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$11.8M | |
| 3 | -$7.71M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$5.13M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$5.1M |